Plasmodium falciparum pre-erythrocytic stage vaccine development

Worldwide strategies between 2010 and 2017 aimed at controlling malarial parasites (mainly Plasmodium falciparum) led to a reduction of just 18% regarding disease incidence rates. Many biologically-derived anti-malarial vaccine candidates have been developed to date; this has involved using many exp...

Full description

Autores:
Molina Franky, Jessica
Cuy Chaparro, Laura
Camargo, Anny
Reyes, César
Gómez, Marcela
Salamanca, David Ricardo
Patarroyo, Manuel Alfonso
Patarroyo, Manuel Elkin
Tipo de recurso:
Article of journal
Fecha de publicación:
2020
Institución:
Universidad de Ciencias Aplicadas y Ambientales U.D.C.A
Repositorio:
Repositorio Institucional UDCA
Idioma:
eng
OAI Identifier:
oai:repository.udca.edu.co:11158/2869
Acceso en línea:
https://malariajournal.biomedcentral.com/track/pdf/10.1186/s12936-020-3141-z
Palabra clave:
Malaria
Ensayo Clínico
Plasmodium falciparum
Esporozoítos
Clinical trial
Immune response
Malaria
Sporozoite
Vaccine
Vaccine efficacy
Rights
openAccess
License
Derechos Reservados - Universidad de Ciencias Aplicadas y Ambientales